Recent Developments and Evolving Therapeutic Strategies in KMT2A‐Rearranged Acute Leukemia

L Yin, L Wan, Y Zhang, S Hua, X Shao - Cancer Medicine, 2024 - Wiley Online Library
Background Rearrangements of the histone‐lysine‐N‐methyltransferase (KMT2A),
previously referred to as mixed‐lineage leukemia (MLL), are among the most common …

Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development

J Li, ML Kalev‐Zylinska - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia
(AML) in which leukemic blasts have megakaryocytic features. AMKL makes up 4%–15% of …

The genetic architecture of fornix white matter microstructure and their involvement in neuropsychiatric disorders

YN Ou, YJ Ge, BS Wu, Y Zhang, YC Jiang… - Translational …, 2023 - nature.com
The fornix is a white matter bundle located in the center of the hippocampaldiencephalic
limbic circuit that controls memory and executive functions, yet its genetic architectures and …

Long Noncoding RNA Expression in Acute Lymphoblastic Leukemia: A Systematic Review

SC Lobo-Alves, LA de Oliveira, GC Kretzschmar… - Critical Reviews in …, 2024 - Elsevier
Long noncoding RNAs (lncRNAs), as gene expression modulators, are potential players in
Acute Lymphoblastic Leukemia (ALL) pathogenesis. We systematically explored current …

Inducible MLL-AF9 expression drives an AML program during human pluripotent stem cell-derived hematopoietic differentiation

BMH Heuts, S Arza-Apalategi, SG Alkema, E Tijchon… - Cells, 2023 - mdpi.com
A t (9; 11)(p22; q23) translocation produces the MLL-AF9 fusion protein, which is found in up
to 25% of de novo AML cases in children. Despite major advances, obtaining a …

Targeting the deubiquitinase USP2 for malignant tumor therapy

S Zhang, Y Guo, S Zhang, Z Wang… - Oncology …, 2023 - spandidos-publications.com
The ubiquitin‑proteasome system is a major degradation pathway for> 80% of proteins in
vivo. Deubiquitylases, which remove ubiquitinated tags to stabilize substrate proteins, are …

EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification

ZY Meng, YC Fan, CS Zhang, LL Zhang, T Wu… - PeerJ, 2023 - peerj.com
Background Hepatocellular carcinoma (HCC) is a common malignant tumor. There are few
studies on EXOSC10 (exosome component 10) in HCC; however, the importance of …

[PDF][PDF] Machine learning-based integration develops multi regulated cell death-related signatures for improving outcomes and immune response in acute myeloid …

L Li, R Zhang, J Li - 2023 - scholar.archive.org
Acute myeloid leukemia (AML) presents an unpredictable and complex prognosis.
Researchers have been exploring different ways to determine the death of cancer cells …

Fluoreszenz-in-situ-Hybridisierung und funktionelle Analyse der KMT2A-MAML2 Translokation in epithelialen Thymusneoplasien und den humanen Zelllinien 1889c …

M Rose - 2024 - ediss.uni-goettingen.de
Hiermit erkläre ich, die Dissertation mit dem Titel „Fluoreszenzin-situ-Hybridisierung und
funktionelle Analyse der KMT2AMAML2 Translokation in epithelialen Thymusneoplasien …

Ku60019 Inhibits Ovarian Cancer Progression by Targeting Dgat1/Has-Mir-1273g-3p Axis

Z Ma, R Dang, G Wu - Available at SSRN 4568783 - papers.ssrn.com
Ataxia telangiectasia mutated (ATM) blockage can induce apoptosis in ovarian cancer.
However, the molecular mechanisms responsible for the processes remain poorly …